z-logo
Premium
Novel mutation in the methyltransferase domain of DNMT 1 in a hereditary sensory and autonomic neuropathy patient with hearing loss, cataract, and dementia
Author(s) -
Nishihara Hideaki,
Yuan Junhui,
Omoto Masatoshi,
Ogasawara Junichi,
Koga Michiaki,
Kawai Motoharu,
Higuchi Yujiro,
Hashiguchi Akihiro,
Takashima Hiroshi,
Kanda Takashi
Publication year - 2015
Publication title -
neurology and clinical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
0
ISSN - 2049-4173
DOI - 10.1111/ncn3.145
Subject(s) - dna methyltransferase , genetics , medicine , mutation , missense mutation , hearing loss , exon , dementia , methyltransferase , biology , audiology , dna , gene , methylation , disease
DNMT 1 encodes DNA methyltransferase 1, which is a critical enzyme responsible for conversion of unmethylated DNA into hemimethylated DNA . To date, two phenotypes produced by DNMT 1 mutations have been reported, including hereditary sensory and autonomic neuropathy type  IE , and autosomal dominant cerebellar ataxia, deafness and narcolepsy. We report a sporadic Japanese patient with dysautonomia, hearing loss, cataract, sensory disturbance and mild dementia. A novel missense mutation, c.4001C>T, was identified in exon 35, which encodes the methyltransferase domain of DNMT 1 . Until now, all reported mutations of DNMT 1 were within the replication focus targeting sequence domain of DNA methyltransferase 1. This is the first report of a mutation in the methyltransferase domain of DNA methyltransferase 1. Our patient showed remarkable autonomic dysfunction along with cataract, a possible new phenotype of DNMT 1 mutations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom